Search
for
Sort by
Research 241–270 of 1000+
- Cronkhite-Canada Syndrome: A Case Report
- Autoamputation in a 45-Year-Old Female with Systemic Lupus Erythematosus Overlap with Systemic Sclerosis: A Case Report
- Editor’s picks January 2021
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review
- Ann Robinson’s research reviews —12 May 2022
- Designing the Future of Dermatology and Venereology
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends
- Severity grading of dermatological emergencies based on comorbidities and systemic involvement: An observational study
- Hair transplantation: A brief review
- Repurposing of H1-receptor antagonists (levo)cetirizine, (des)loratadine, and fexofenadine as a case study for systematic analysis of trials on clinicaltrials.gov using semi-automated processes with custom-coded software
- An update of polycystic ovary syndrome: causes and therapeutics options
- Genetic and hormonal influence on SARS-CoV-2-infection susceptibility
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Epidermal stem cells: skin surveillance and clinical perspective
- Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- Male sex hormones, aging, and inflammation
- Recommendations on trichological treatments during COVID-19 pandemic
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- Time of onset and duration of post-COVID-19 acute telogen effluvium
- Evaluating the Role of Thyroid Stimulating Hormone and Ferritin Levels with Hair Loss among Patients with COVID-19: Case-Control Study
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms